Results of the CONTROL Trial: Efficacy and Safety of Recombinant Activated Factor VII in the Management of Refractory Traumatic Hemorrhage
Carl J. Hauser(Beth Israel Deaconess Medical Center), Bertil Bouillon(Witten/Herdecke University), John B. Holcomb(Universidad Mayor), Michael Parr, Gordon R. Bernard(Vanderbilt University Medical Center), Jeannett Dimsits, Kenneth D Boffard, Richard P. Dutton(University of Maryland, Baltimore), Ari Leppäniemi, Jean‐Louis Vincent(Université Libre de Bruxelles), Bartholomew J. Tortella(Pfizer (United States)), Martin A. Croce(Emanuel University)
The Journal of Trauma: Injury, Infection, and Critical Care
September 1, 2010
Cited by 347
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k